Previous studies identified that BMI1+ CSCs were resistant to cisplatin treatment in HNSCC 15, 19, 46, and SOX2 is another important transcription factor regulating CSC properties 47. The gene discussed is BMI1; the disease is head and neck squamous cell carcinoma.